Drugs

A woman is suing Novo Nordisk and Eli Lilly, claiming they did not properly warn patients about certain side effects of Ozempic and Mounjaro medications that have surged in popularity.

Merck & Co. is digging its heels in against the Biden administration in a lawsuit over the constitutionality of HHS' drug pricing program, asking the court to rule without a trial.

Alzheimer’s drug Leqembi received full approval from the U.S. Food and Drug Administration. An expert explains why this is a milestone in the treatment of the progressive disease.

The Centers for Disease Control and Prevention (CDC) is investigating a multinational outbreak of fungal meningitis that has already killed four people.

TikTok users have been testing out berberine, which is an herbal supplement, that is gaining popularity for its alleged weight loss effects.

China-based companies suspected of producing chemicals for illicit fentanyl manufacturing have received at least $38 million in cryptocurrency payments since 2018, Chainalysis says.

AI-driven technology developed by VeriSIM Life accelerates drug development and reduces the need for animal testing by analyzing pharmaceuticals before human trials.

Pfizer's oral diabetes drug could join the lineup of sought-after drugs tackling weight loss. A recent study showed promising weight loss results in those with Type 2 diabetes.

2022 marked the year that drug tests administered following workplace accidents showing positive results for marijuana reached the highest level in 25 years: Quest Diagnostics.

San Francisco said on Wednesday it reached a $230 million settlement with Walgreens Boots Alliance Inc over its role in the city’s opioid epidemic.

The Food and Drug Administration is nearing its decision on whether to allow HRA Pharma to sell its Opill birth control pill in the U.S. without requiring a prescription.

Family Dollar issued another recall for several over-the-counter drug products after discovering they were not stored under proper conditions, according to a notice from the FDA.

Novo Nordisk will only be able to supply limited quantities of certain Wegovy dose strengths to U.S. retail pharmacies given the surge in demand for the product.

Entrepreneurs in Vancouver are offering psilocybin "journeys" for clients seeking what they describe as "the highest level of self-discovery and personal development."

Experts say national drug shortages, caused by manufacturing problems, demand spikes, and tightened ingredient supply lines, have no clear resolution and could persist for years.

Eli Lilly's tirzepatide, which is approved to treat Type 2 diabetes and sold under the brand name Mounjaro, could become the most effective weight loss treatment.

Demand for medications including Ozempic, for weight loss use, led to shortages that sometimes deprived people with diabetes of their prescription refills.

Americans are spending more money on legal cannabis purchases than they are spending on chocolate, craft beer, opioid medications or topical pain relief.

Emergent BioSolutions is aiming to make Narcan more affordable after the Food and Drug Administration approved sales of the live-saving without a prescription.

Moderna shares are down Tuesday on news that the biotech's potential flu vaccine will need further review to determine its efficacy against influenza.